Ben T. G. Tan
No más puestos en curso
Origen de la red de primer grado Ben T. G. Tan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
49
| Public Company | Pharmaceuticals: Major | 49 |
21
| Public Company | Pharmaceuticals: Major | 21 |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium.
4
| Subsidiary | Biotechnology | 4 |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ben T. G. Tan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| Stanford University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
| UCB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ABLYNX | Biotechnology | General Counsel Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Basel | College/University | Corporate Officer/Principal Doctorate Degree | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| MONDELEZ INTERNATIONAL, INC. | Food: Specialty/Candy | Corporate Officer/Principal Chief Executive Officer | |
Mars, Inc.
 Mars, Inc. Food: Specialty/CandyConsumer Non-Durables Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal | |
| HONEYWELL INTERNATIONAL INC. | Aerospace & Defense | Director/Board Member Corporate Officer/Principal | |
| The University of North Carolina at Chapel Hill | College/University | Graduate Degree Doctorate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Director/Board Member Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree Doctorate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Masters Business Admin | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Ghent University | College/University | Corporate Officer/Principal Doctorate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
| University of Buenos Aires School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO |
Estadísticas
Internacional
| Estados Unidos | 30 |
| Suiza | 5 |
| Bélgica | 5 |
| Reino Unido | 4 |
| Países Bajos | 3 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 16 |
| Commercial Services | 4 |
| Finance | 3 |
| Consumer Non-Durables | 3 |
Operativa
| Director/Board Member | 481 |
| Corporate Officer/Principal | 228 |
| Independent Dir/Board Member | 158 |
| Chairman | 75 |
| Chief Executive Officer | 64 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| James Healy | 50 |
| Ed Mathers Mathers | 47 |
| Ann Marie Fudge | 40 |
| William Brody | 40 |
| Hans-Jörg Rudloff | 31 |
| Rudy Dekeyser | 29 |
| Shervin Korangy | 27 |
| Jonathan Symonds | 24 |
| Pablo Cagnoni | 24 |
| Anne VanLent | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Viviane Monges | 22 |
| Barbara Duncan | 22 |
| Jonathan Peacock | 21 |
| William George | 21 |
- Bolsa de valores
- Insiders
- Ben T. G. Tan
- Conexiones Empresas
